B

Biome Australia Ltd
ASX:BIO

Watchlist Manager
Biome Australia Ltd
ASX:BIO
Watchlist
Price: 0.535 AUD -1.83% Market Closed
Market Cap: 117.2m AUD
Have any thoughts about
Biome Australia Ltd?
Write Note

Biome Australia Ltd
Inventory

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biome Australia Ltd
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
B
Biome Australia Ltd
ASX:BIO
Inventory
AU$1.9m
CAGR 3-Years
23%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Bioxyne Ltd
ASX:BXN
Inventory
AU$2.1m
CAGR 3-Years
80%
CAGR 5-Years
25%
CAGR 10-Years
N/A
McPherson's Ltd
ASX:MCP
Inventory
AU$25.7m
CAGR 3-Years
-19%
CAGR 5-Years
-7%
CAGR 10-Years
-6%
Star Combo Pharma Ltd
ASX:S66
Inventory
AU$6.3m
CAGR 3-Years
12%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Elixinol Wellness Ltd
ASX:EXL
Inventory
AU$3.7m
CAGR 3-Years
-8%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
H
Hydration Pharmaceuticals Co Ltd
ASX:HPC
Inventory
$2.4m
CAGR 3-Years
15%
CAGR 5-Years
18%
CAGR 10-Years
N/A
No Stocks Found

Biome Australia Ltd
Glance View

Market Cap
115.1m AUD
Industry
Consumer products

Biome Australia Ltd. engages in the development and marketing of live biotherapeutics and complementary medicines. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-11-30. The firm licenses, develops and markets evidence-based, complementary medicines, including nutraceuticals (food-based vitamins and weight management products) and live biotherapeutics (probiotics). The company markets and distributes clinically researched products developed in conjunction with its strategic partners. Its products include 22 products marketed under three brands, being Activated Probiotics, Activated Nutrients and Activated X Performance. These products are distributed through community pharmacies, independent health practitioners and online direct to consumer channels. The company offers biotherapeutic products to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema and irritable bowel syndrome (IBS), through randomized double-blind placebo-controlled trials.

BIO Intrinsic Value
0.34 AUD
Overvaluation 36%
Intrinsic Value
Price
B

See Also

What is Biome Australia Ltd's Inventory?
Inventory
1.9m AUD

Based on the financial report for Jun 30, 2024, Biome Australia Ltd's Inventory amounts to 1.9m AUD.

What is Biome Australia Ltd's Inventory growth rate?
Inventory CAGR 5Y
33%

Over the last year, the Inventory growth was -37%. The average annual Inventory growth rates for Biome Australia Ltd have been 23% over the past three years , 33% over the past five years .

Back to Top